Serum Concentrations of s100b and NSE in Migraine

被引：50
作者：
Teepker, Michael [1 ]
Munk, Karoline [1 ]
Mylius, Veit [1 ]
Haag, Anja [1 ]
Moeller, Jens C. [1 ]
Oertel, Wolfgang H. [1 ]
Schepelmann, Karsten [1 ]
机构：
[1] Philipps Univ Marburg, Dept Neurol, D-35039 Marburg, Germany
来源：
HEADACHE | 2009年 / 49卷 / 02期
关键词：
s100b; neuron-specific enolase; migraine; blood-brain barrier; NEURON-SPECIFIC ENOLASE; ACUTE ISCHEMIC-STROKE; NO PREVIOUS HISTORY; CEREBROSPINAL-FLUID; S-100; PROTEIN; SPREADING DEPRESSION; ACIDIC PROTEIN; USEFUL MARKER; BRAIN; S100-BETA;
D O I：
10.1111/j.1526-4610.2008.01228.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The protein s100b indicates astrocytal damage as well as dysfunction of the blood-brain barrier (BBB), and neuron-specific enolase (NSE) is regarded as a marker for neuronal cell loss. Recently, s100b was shown to be a potentially useful marker for migraine in children. In this study, we investigated the levels of s100b and NSE in adult migraineurs during and after migraine attacks in order to gain some more insight into migraine pathophysiology. Serum levels of s100b and NSE were measured in 21 migraineurs and compared with 21 healthy subjects matched by sex and age. In migraineurs, blood samples were taken during a migraine attack and following a pain-free period of 2-4 days. During migraine attacks elevated s100b levels could be observed. Maximal concentrations were detected in the pain-free period after 2-4 days. Regarding NSE, serum levels were decreased slightly during and after migraine bouts. Our data suggest a prolonged disruption of BBB during and after migraine attacks. Other possible explanations concerning the detected serum levels of s100b and NSE will be discussed; however, neuronal cell death can be ruled out by the decreased serum concentrations of NSE. With regard to the results of the present study, further research is necessary to evaluate the role of s100b and NSE in migraine.
引用
收藏
页码：245 / 252
页数：8
相关论文
共 50 条
[1]  
ALVAREZCERMENO J, 1986, HEADACHE, V26, P437
[2]   Neuron-specific enolase as a marker for acute ischemic stroke: A systematic review [J].
Anand, N ;
Stead, LG .
CEREBROVASCULAR DISEASES, 2005, 20 (04) :213-219
[3]   ABNORMAL BRAIN AND MUSCLE ENERGY-METABOLISM SHOWN BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY IN PATIENTS AFFECTED BY MIGRAINE WITH AURA [J].
BARBIROLI, B ;
MONTAGNA, P ;
CORTELLI, P ;
FUNICELLO, R ;
IOTTI, S ;
MONARI, L ;
PIERANGELI, G ;
ZANIOL, P ;
LUGARESI, E .
NEUROLOGY, 1992, 42 (06) :1209-1214
[4]   Reliability of S100B in predicting severity of central nervous system injury [J].
Bloomfield, Stephen M. ;
McKinney, James ;
Smith, Les ;
Brisman, Jonathan .
NEUROCRITICAL CARE, 2007, 6 (02) :121-138
[5]  
Camby I, 1999, BRAIN PATHOL, V9, P1
[6]   Serum S100B protein levels are correlated with subclinical, neurocognitive declines after carotid endarterectomy [J].
Connolly, ES ;
Winfree, CJ ;
Rampersad, A ;
Sharma, R ;
Mack, WJ ;
Mocco, J ;
Solomon, RA ;
Todd, G ;
Quest, DO ;
Stern, Y ;
Heyer, EJ .
NEUROSURGERY, 2001, 49 (05) :1076-1082
[7]   Protein S-100b serum levels in trauma-induced brain death [J].
Dimopoulou, I ;
Korfias, S ;
Dafni, U ;
Anthi, A ;
Psachoulia, C ;
Jullien, G ;
Sakas, DE ;
Roussos, C .
NEUROLOGY, 2003, 60 (06) :947-951
[8]   S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles [J].
Donato, R .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (07) :637-668
[9]   Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II [J].
Dreier, JP ;
Jurkat-Rott, K ;
Petzold, GC ;
Tomkins, O ;
Klingebiel, R ;
Kopp, UA ;
Lehmann-Horn, F ;
Friedman, A ;
Dichgans, M .
NEUROLOGY, 2005, 64 (12) :2145-2147
[10]   Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction [J].
Foerch, C ;
Singer, OC ;
Neumann-Haefelin, T ;
de Rochemont, RDM ;
Steinmetz, H ;
Sitzer, M .
ARCHIVES OF NEUROLOGY, 2005, 62 (07) :1130-1134
12345